A specialised centre providing the most advanced haematology treatments
The Princess Grace Hospital provides the most advanced techniques and technologies for the treatment of cancer, from some of the world’s leading consultants. As part of this service Leukaemia Excellence Ltd and North London Haematology Services Ltd, led by Dr Panos Kottaridis and Dr Christopher McNamara offers excellent clinical and academic experience in haematology. The consultants have particular expertise in Hodgkin lymphoma, acute myeloid leukaemia and haematological malignancies, with special interest in treatments involving bone marrow transplantation and radio-immunotherapy.
They are established members of the field, holding posts at Royal Free Hospital and University College London Hospital. Dr McNamara has worked extensively in the development of treatment guidelines for haematology patients, nationally with the British Committee for Standardisation in Haematology, and internationally with the European Society of Medical Oncology. Dr Kottaridis is a key member of the National Cancer Research Institute, has published more than 65 papers in leading journals, with more than 3000 citations in scientific papers, and contributes to training at The Royal Free Campus of UCL Medical School.
Services provided to HCA
These doctors provide medical advisory services for HCA's The Princess Grace Hospital in leukaemia treatment excellence. In their role, they lead interactions with hospital medical staff and the hospital leadership team to assist the hospital by providing medical advice and promote high quality, cost effective care.
In their role, they contribute to the strategy, policies and decision making regarding leukaemia services and advise HCA to ensure that care provided within the facility is appropriate and efficient. In their role, they advise on initiatives to drive clinical standards by providing professional advice on clinical governance matters and ensuring the adoption of those by colleagues in the leukaemia services area.
In addition, they work with medical insurance companies, GPs, other relevant local NHS contacts, and patients to educate and advise on relevant clinical updates to treatments in leukaemia services available in the facility. Furthermore, they advise on the accuracy of literature that may be published regarding relevant services. They will also advise on how to make the patient referral smooth to reduce stress and anxiety for patients.
HCA UK is charged by doctors in return for their expertise and advice, including on how to operate safe hospital facilities delivering complex care. All services provided under this agreement are charged to HCA UK.
From January to December 2017, the total charge for Dr Christopher Mcnamara was £14,960.
HCA requires the doctors that advise us to attest that if they also practice in the NHS that they are not compromising their NHS commitments.
The information disclosed on this page in accordance with the Private Healthcare Market Investigation Order 2014 is true and accurate to the best of HCA’s knowledge and belief.